Houston Methodist researchers shed light on increa | Newswise

Houston Methodist researchers shed light on increa | Newswise

Newswise — HOUSTON-(Nov. 1, 2024) – A concerning increase in global rates of severe invasive infections becoming resistant to key antibiotics has a team of infectious disease researchers at the Houston Methodist Research Institute studying a recently emerged strain of bacteria called Streptococcus dysgalactiae subspecies equisimilis (SDSE). SDSE infects humans via the skin, throat, gastrointestinal…

Read More
New Addition to Standard-of-Care Treatments for No | Newswise

New Addition to Standard-of-Care Treatments for No | Newswise

Newswise — Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations could significantly extend progression-free survival for patients with non-small-cell lung cancer (NSCLC), the most common type of lung cancer.  Through advanced mathematical modeling, a team led by Prashant Dogra, Ph.D., and Zhihui “Bill” Wang, Ph.D., from the Mathematics…

Read More